ID: h-658167b004
Hypothesis

GDNF-RET Trophic Signaling Deficit

Healthy astrocytes secrete GDNF, which activates RET receptor signaling on motor neurons, promoting microtubule-dependent transport of RNA-binding proteins and preventing TDP-43 mislocalization.
🧬 GDNF; RET; VCP🩺 neurodegeneration🎯 Composite 53%💱 $0.53▼1.1%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 4 oppose
✓ All Quality Gates Passed
Mechanistic 0.55 (15%) Evidence 0.50 (15%) Novelty 0.55 (12%) Feasibility 0.55 (12%) Impact 0.60 (12%) Druggability 0.35 (10%) Safety 0.55 (8%) Competition 0.50 (6%) Data Avail. 0.60 (5%) Reproducible 0.60 (5%) KG Connect 0.50 (8%) 0.530 composite

🧪 Overview

Healthy astrocytes secrete GDNF, which activates RET receptor signaling on motor neurons, promoting microtubule-dependent transport of RNA-binding proteins and preventing TDP-43 mislocalization. Hypoxic/ALS astrocytes show decreased GDNF secretion, disrupting this protective axis. However, this hypothesis is weakly anchored to the specific RBP-localization phenotype in the VCP/hypoxia system and faces substantial delivery challenges for translation.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["VCP/p97 AAA+ ATPase<br/>CHIP-Dependent Degradation Complex"]
    B["ER-Associated Degradation (ERAD)<br/>Ubiquitinated Substrate Extraction"]
    C["AGFG1 and ArfGAP1 Interaction<br/>Vesicle Trafficking and Autophagosome Maturation"]
    D["TDP-43 and FUS Extraction<br/>Nuclear Quality Control Failure Compensation"]
    E["VCP Mutation (Multisystem Proteinopathy)<br/>Degeneration of Neurons and Muscle"]
    F["Inclusion Body Myopathy and Frontotemporal Dementia<br/>Pathologic Aggregate Accumulation"]
    G["VCP Inhibitor Therapeutic Strategy<br/>Preclinical Validation Needed"]
    A --> B
    B --> C
    C --> D
    E --> F
    F --> G
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix3 supports4 contradicts
Supports
GDNF administration protects motor neurons in SOD1 mouse models
Supports
Astrocyte-derived GDNF is reduced in ALS patient tissue
Supports
RET activation enhances retrograde transport
Contradicts
The mechanistic chain from GDNF to RBP trafficking correction is long and unsupported in this specific system
Contradicts
Many ALS trophic-factor programs have shown limited translational benefit despite preclinical neuroprotection
Contradicts
CNS trophic-factor programs have repeatedly struggled with delivery and clinical effect
Contradicts
Immunodeplete GDNF from healthy CM and rescue is largely lost; this falsification has not been performed
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — GDNF;

No curated PDB or AlphaFold mapping for GDNF; yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for GDNF; RET; VCP from GTEx v10.

Cerebellum3.2 Cerebellar Hemisphere3.2 Putamen basal ganglia0.5 Nucleus accumbens basal ganglia0.4 Caudate basal ganglia0.4 Spinal cord cervical c-10.3 Hippocampus0.3 Substantia nigra0.2 Hypothalamus0.2 Amygdala0.2 Frontal Cortex BA90.2 Cortex0.2 Anterior cingulate cortex BA240.1median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GDNF; RET; VCP →

No DepMap CRISPR Chronos data found for GDNF; RET; VCP.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0080
Events (7d)
1
Price History
▼1.1%

💾 Resource Usage

LLM Tokens
10,463
$0.0314
Total Cost
$0.0314

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF human iPSC-derived motor neurons are co-cultured with hypoxic preconditioned astrocytes (2% O2, 48h) AND exogenous GDNF (100 ng/mL) is added to the culture medium, THEN TDP-43 nuclear localization TDP-43 nuclear/cytoplasmic ratio will be ≥0.70 in GDNF-treated hypoxic co-cultures vs. ≤0.50 in untreated hypoxic co-cultures, as measured by immunofluorescence— no observation —pending0.55
IF primary murine spinal motor neurons are treated with the selective RET inhibitor RPI-1 (10 μM) or RET-targeted siRNA for 48 hours, THEN TDP-43 mislocalization (cytoplasmic accumulation) will increaCytoplasmic TDP-43 intensity will increase to ≥1.5-fold relative to nuclear TDP-43 in RET-inhibited neurons, with ≥50% reduction in p-ERK1/2/total ERK ratio, as— no observation —pending0.48
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF human iPSC-derived motor neurons are co-cultured with hypoxic preconditioned astrocytes (2% O2, 48h) AND exogenous GDNF (100 ng/mL) is added to the culture medium, THEN TDP-43 nuclear localization will increase by ≥30% compared to hypoxic co-cultures without GDNF within 72 hours of GDNF treatment
Predicted outcome: TDP-43 nuclear/cytoplasmic ratio will be ≥0.70 in GDNF-treated hypoxic co-cultures vs. ≤0.50 in untreated hypoxic co-cultures, as measured by immunofl
Falsification: TDP-43 nuclear/cytoplasmic ratio remains ≤0.50 in GDNF-treated hypoxic co-cultures, indistinguishable from untreated controls (p>0.05, Mann-Whitney U test), indicating GDNF supplementation does not re
pendingconf 48%
IF primary murine spinal motor neurons are treated with the selective RET inhibitor RPI-1 (10 μM) or RET-targeted siRNA for 48 hours, THEN TDP-43 mislocalization (cytoplasmic accumulation) will increase by ≥40% compared to vehicle-treated neurons, with concurrent reduction in phosphorylated ERK1/2 (
Predicted outcome: Cytoplasmic TDP-43 intensity will increase to ≥1.5-fold relative to nuclear TDP-43 in RET-inhibited neurons, with ≥50% reduction in p-ERK1/2/total ERK
Falsification: TDP-43 localization remains unchanged (cytoplasmic/nuclear ratio <1.2-fold) and p-ERK levels are unaffected by RET inhibition (p>0.05), indicating RET signaling is not upstream of TDP-43 regulation in
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.